Definium Therapeutics (DFTX) Interest Expenses (2023 - 2026)
Definium Therapeutics (DFTX) recorded Interest Expenses of $1.23 million in Q2 2026, down 47.3% from $2.34 million a year earlier and down 1.0% from the prior quarter.
Powered by 
Analysis
Definium Therapeutics (DFTX) Interest Expenses (2023 - 2026) Analysis & Trends
On a TTM basis, Definium Therapeutics' Interest Expenses came in at $5.06 million as of Jun 30, 2026, up 17.1% year-over-year; for FY2025, it was $5.5 million, up 140.9% from FY2024.
- Across earlier years, Interest Expenses came in at $2.28 million in FY2024 (+148.2%) and $920,000 in FY2023.
- The Q2 2026 figure is the lowest quarterly Interest Expenses since Q1 2025.
- On a year-over-year basis, Interest Expenses rose in seven of the last eight quarters, with growth averaging 105.7%.
- Peak year-over-year performance for Interest Expenses in the last five years was growth of 505.2% in Q2 2024, against a decline of 47.3% in Q2 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at $1.25 million (Q1 2026), $1.29 million (Q4 2025) and $1.3 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 217.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | -477.00 Mn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 653.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 269.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Definium Therapeutics | 4.74 Bn | 1.83 Bn | - | 1.15 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 1.15 Mn |
| Jun 30, 2026 | 1.23 Mn |
| Mar 31, 2026 | 1.25 Mn |
| Dec 31, 2025 | 1.29 Mn |
| Sep 30, 2025 | 1.27 Mn |
| Jun 30, 2025 | 2.34 Mn |
| Mar 31, 2025 | 602,000.00 |
| Dec 31, 2024 | 656,000.00 |
| Sep 30, 2024 | 727,000.00 |
| Jun 30, 2024 | 466,000.00 |
| Mar 31, 2024 | 434,000.00 |
| Dec 31, 2023 | 439,000.00 |
| Sep 30, 2023 | 328,000.00 |
| Jun 30, 2023 | 77,000.00 |
| Mar 31, 2023 | 76,000.00 |
API Access
Definium Therapeutics Interest Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-expenses&ticker=DFTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-expenses", "ticker": "DFTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-expenses&ticker=DFTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();